- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06026007
Efficacy of Acupressure Versus Traditional Treatment on Reducing Ankle Edema During Pregnancy
September 7, 2023 updated by: Noha Ahmed Fouad Abd-Elrahman, Badr University
Incidence of ankle edema is high during pregnancy, If left untreated, it may lead to difficulty walking; stiffness; stretched skin which can become itchy and uncomfortable.
Acupressure promotes the condition of the circulatory and lymphatic system leading to the elimination of edema.
The aim of this study is to investigate the efficacy of acupressure versus traditional physical therapy treatment on ankle edema during pregnancy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sixty pregnant women aged 25 to 35 years old and body mass index was ≥ 30 kg/m², will participate in this study.
They will be assigned into three equal groups, Group A will receive only traditional physical therapy protocol in the form of advice including elevation, wearing supportive stocking, and avoiding standing in one position for extended periods, and Group B will receive the same traditional treatment as group A in addition to circulatory exercises, 3times per week for 4 weeks; while Group C will receive the same conventional physical therapy protocol in addition to foot acupressure 3times per week for 4 weeks.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Giza, Egypt, 11432
- Faculty of Physical Therapy Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- pregnant women in their third trimester,
- age ranged from 25-35 years and
- BMI was ≥30Kg/m2.
Exclusion Criteria:
- Pregnant women with skin diseases
- irremovable bracelet,
- decreased functional active range of motion in the affected lower extremity
- any mental or physical disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control group
patient in this group received advice only for edema relief
|
each pregnant woman was advices how to elevate her legs and daily positions to elevate edema
Other Names:
|
|
Experimental: Circulatory exercise group
patient in this group received advice in addition to circulatory exercise for edema relief
|
each pregnant woman was advices how to elevate her legs and daily positions to elevate edema
Other Names:
each pregnant woman was advised about daily routine in addition to circulatory exercise
Other Names:
|
|
Experimental: Acupressure group
patient in this group received advice in addition to acupressure for edema relief
|
each pregnant woman was advices how to elevate her legs and daily positions to elevate edema
Other Names:
each pregnant woman was advised about daily routine in addition to acupressure therapy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in foot and ankle edema during pregnancy
Time Frame: Before starting study and after four weeks of intervention
|
Foot Volumeter was used to assess foot and ankle edema
|
Before starting study and after four weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
level of swelling
Time Frame: Before starting study and after 4 weeks of intervention
|
Patient reported oedema Questionnaire was used to determine the level of swelling
|
Before starting study and after 4 weeks of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: noha abd el rhaman, doctoral, BUC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2022
Primary Completion (Actual)
March 30, 2022
Study Completion (Actual)
May 8, 2022
Study Registration Dates
First Submitted
July 30, 2022
First Submitted That Met QC Criteria
September 3, 2023
First Posted (Actual)
September 6, 2023
Study Record Updates
Last Update Posted (Actual)
September 11, 2023
Last Update Submitted That Met QC Criteria
September 7, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
only data of the study will be shared
IPD Sharing Time Frame
data will become available after publication
IPD Sharing Access Criteria
data will become available after publication
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Edema
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
Alexandria UniversityRecruitingDiabetic Macular Edema | Center-involved Diabetic Macular EdemaEgypt
-
Tel-Aviv Sourasky Medical CenterUnknownSmall for Gestational Age Infants | Appropriate for Gestational Age InfantsIsrael
-
Curacle Co., Ltd.Not yet recruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DME
-
Hoffmann-La RocheCompletedDiabetic Macular Edema | Uveitic Macular EdemaUnited States
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
National Cardiovascular Center Harapan Kita Hospital...CompletedMyocardial Edema
Clinical Trials on advices
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
University of SevilleCompleted
-
Doha Ali Amin AhmedCairo UniversityRecruitingChronic Mechanical Low Back PainEgypt
-
Cairo UniversityNot yet recruitingUrinary Stress Incontinence
-
Cairo UniversityRecruitingCervical Pain | Cervical Joint Position ErrorEgypt
-
Cairo UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityRecruiting
-
Centre Hospitalier Universitaire VaudoisRecruitingSurgery | Time Restricted FeedingSwitzerland, United States
-
University of OsloActive, not recruiting